🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Loïc Verlingue

Centre de Recherche en Cancérologie de Lyon

ORCID: 0000-0002-5694-4022

Computer ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)”.

96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)

Journal of Thoracic Oncology(2025)10.1016/s1556-0864(25)00291-6

N/A

0DataRank · unranked

4 citations

N. Klümper, M. Eckstein, Johannes Braegelmann, Meredith McKean, A. Italiano +15 more

134TiP: Evaluation of an additional cohort of patients with non-small cell lung cancer (NSCLC) in the phase I/II duravelo-1 study of zelenectide pevedotin (BT8009), a bicycle toxin conjugate

Journal of Thoracic Oncology(2025)10.1016/s1556-0864(25)00329-6

N/A

0DataRank · unranked

0 citations

Loïc Verlingue, A. Italiano, L. Carter, Gerald S. Falchook, Valentina Boni +13 more

414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer

ESMO Open(2025)10.1016/j.esmoop.2025.104985

N/A

0DataRank · unranked

0 citations

G.S. Falchook, Loïc Verlingue, L. Carter, Thibault De La Motte Rouge, C. Baldini +14 more